Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe In Vitro Toxicity Testing Market, by Type
1.4.2 Europe In Vitro Toxicity Testing Market, by Technology
1.4.3 Europe In Vitro Toxicity Testing Market, by End User
1.4.4 Europe In Vitro Toxicity Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe In Vitro Toxicity Testing Market by Type
3.1 Europe Absorption Market by Country
3.2 Europe Toxic Substances Market by Country
3.3 Europe Dose Market by Country
Chapter 4. Europe In Vitro Toxicity Testing Market by Technology
4.1 Europe Cell Culture Technologies Market by Country
4.2 Europe High Throughput Technologies Market by Country
4.3 Europe Toxicogenomics Market by Country
Chapter 5. Europe In Vitro Toxicity Testing Market by End User
5.1 Europe Cosmetics & Households Products Market by Country
5.2 Europe Pharmaceuticals Industry Market by Country
5.3 Europe Food Industry Market by Country
5.4 Europe Chemicals Industry Market by Country
Chapter 6. Europe In Vitro Toxicity Testing Market by Country
6.1 Germany In Vitro Toxicity Testing Market
6.1.1 Germany In Vitro Toxicity Testing Market by Type
6.1.2 Germany In Vitro Toxicity Testing Market by Technology
6.1.3 Germany In Vitro Toxicity Testing Market by End User
6.2 UK In Vitro Toxicity Testing Market
6.2.1 UK In Vitro Toxicity Testing Market by Type
6.2.2 UK In Vitro Toxicity Testing Market by Technology
6.2.3 UK In Vitro Toxicity Testing Market by End User
6.3 France In Vitro Toxicity Testing Market
6.3.1 France In Vitro Toxicity Testing Market by Type
6.3.2 France In Vitro Toxicity Testing Market by Technology
6.3.3 France In Vitro Toxicity Testing Market by End User
6.4 Russia In Vitro Toxicity Testing Market
6.4.1 Russia In Vitro Toxicity Testing Market by Type
6.4.2 Russia In Vitro Toxicity Testing Market by Technology
6.4.3 Russia In Vitro Toxicity Testing Market by End User
6.5 Spain In Vitro Toxicity Testing Market
6.5.1 Spain In Vitro Toxicity Testing Market by Type
6.5.2 Spain In Vitro Toxicity Testing Market by Technology
6.5.3 Spain In Vitro Toxicity Testing Market by End User
6.6 Italy In Vitro Toxicity Testing Market
6.6.1 Italy In Vitro Toxicity Testing Market by Type
6.6.2 Italy In Vitro Toxicity Testing Market by Technology
6.6.3 Italy In Vitro Toxicity Testing Market by End User
6.7 Rest of Europe In Vitro Toxicity Testing Market
6.7.1 Rest of Europe In Vitro Toxicity Testing Market by Type
6.7.2 Rest of Europe In Vitro Toxicity Testing Market by Technology
6.7.3 Rest of Europe In Vitro Toxicity Testing Market by End User
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 General Electric (GE) Co.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Catalent, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Laboratory Corporation of America Holdings (Covance, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Acquisition and Mergers:
7.6 Acacia Pharma Group Plc
7.6.1 Company Overview
7.7 GlaxoSmithKline PLC (TESARO, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Helsinn Healthcare SA.
7.8.1 Company Overview
7.9 Heron Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
Unique Offerings 